Hélène Péré - Concepedia

Author

Hélène Péré

Also Known As

AP-HP CoMPap (Consultation Multidisciplinaire Papillomavirus) group, C Jung, H Péré, H. Pere, H. Père, H. Pére, H. Péré, Helene Pere, Helene Pr, Helene Péré

192

Publications

13.8K

Citations

H-Index

Concepts

All Affiliations

Université Paris Cité Hôpital Européen Georges-Pompidou Inserm Hôpital Européen Assistance Publique – Hôpitaux de Paris

About

Hélène Péré is an author at Université Paris Cité specializing in medicine, immunology, and covid-19.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	29	7.2K
2	Public Health	2	2	24
3	Allergy	2	2	209
4	Health Sciences	1	1	17
5	Cell Biology	1	1	131

Hélène Péré

Publications

12.6K

Citations

H-Index

Page 1

	Year	Citations
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients Jérôme Hadjadj, Nader Yatim, Laura Barnabei, Science	2020	3.1K
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization Delphine Planas, David Veyer, Artem Baidaliuk, Nature Reduced SensitivityVaccine TargetImmunologyAntibody EngineeringImmunotherapy	2021	2.2K
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization Delphine Planas, Nell Saunders, Piet Maes, Nature Vaccine TargetImmunologyAntibody ScreeningAntibody EngineeringImmunotherapy	2021	1.6K
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies Delphine Planas, Timothée Bruel, Ludivine Grzelak, Nature Medicine Viral DiagnosticsVaccine TargetImmunologyVirologyInfectious Sars-cov-2 B.1.1.7	2021	766
PD-1–Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer Cécile Badoual, Stéphane Hans, Nathalie Merillon, Cancer Research Neck CancerHpv-associated HeadT-regulatory CellImmunologyCell Death	2012	623
Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies Timothée Bruel, Jérôme Hadjadj, Piet Maes, Nature Medicine Humoral ResponseImmunologySerologic TestingAntibody ScreeningMonoclonal Antibodies	2022	305
Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19 Thomas Hueso, Cécile Pouderoux, Hélène Péré, Blood	2020	297
Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals Delphine Planas, David Veyer, Artem Baidaliuk, Viral DiagnosticsImmunologyImmunodominanceCovid-19Viral Evolution	2021	282
Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients Jérôme Hadjadj, Nader Yatim, Laura Barnabei, ImmunodeficienciesImmunologySevere Covid-19 PatientsImmune SystemCovid-19	2020	253
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion Delphine Planas, Isabelle Staropoli, Vincent Michel, Nature Communications	2024	214

Page 1